Preventive Nutrition and Food Science

The Korean Society of Food Science and Nutrition (한국식품영양과학회)
권호 표지

Diabetic Atherosclerosis and Glycation of LDL(Low Density Lipoprotein)

  • Published : 1996.06.01
Download PDF
⟨ Previous Next ⟩

Abstract

Diabetes carries an increased risk of atherosclerotic disease that is not fully explained by known car-diovascular risk factors. There is accumulating evidence that advanced glycation of structural proteins, and oxidation and glycation of circulating lipoproteins, are implicated in the pathogenesis of diabetic ather-osclerosis. Reactions involving glycation and oxidation of proteins and lipids are believed to contribute to atherogenesis. Glycation, the nonenzymatic binding of glucose to protein molecules, can increase the ather-ogenic potential of certain plasma constituents, including low density lipoptotein(LDL). Glycation of LDL is significant increased in diabetic patients compared with normal subjects, even in the presence of good glycemic control. Metabolic abnormalities associated with glycation of LDL include diminished recognition of LDL by the classic LDL receptor; increased covalent binding of LDL in vessel walls ; enhanced uptake of LDL by the macrophages, thus stimulating foam cell formation ; increased platelet aggregation; formation of LDL-immune complexes ; and generation of oxygen free radicals, resulting on oxidative damage to both the lipid and protein components of LDL and to any nearby macromolecules. Oxidized lipoproteins are characterzied by cytotoxicity, potent stimulation of foam cell formation by macrophages, and procoagulant effects. Combined glycation and oxidation, "glycoxidation" occurs when oxidative reactions affect the initial products of glycation, and results in irreversible structural alterations of proteins. Glycoxidation is of greatest significance in long lived proteins such as collagen. In these proteins, glycoxidation products, believed to be atherogenic, accumulate with advancing age : in diabetes, their rate of accumulate is accelerated. Inhibition of glycation, oxidation and glycoxidation may form the basis of future antiaterogenic strategies in both diabetic and nondiabetic individuals.dividuals.

Keywords

References

  1. JAMA v.241 Diabetes and cardiovascular disease : Framingham study Kannel,W.B.;McGee,D.L.
  2. Diabetes v.41 Association of HbAlc with prevalent cardiovascular disease in the original cohort of the Framingham Study Singer,D.E.;Nathan,D.M.;Anderson,K.M.;Wilson,P.W.F.;Evans,J.C.
  3. N. Engl. J. Med. v.318 Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications Brownlee,M.;Cerami,A.;Vlassara,H.
  4. Diabetes v.40 Role of oxidated stress in development of complications in diabetes Baynes,J.W.
  5. Diabetes v.41 Lipoprotein glycation and its metabolic consequences Lyons,T.J.
  6. Glucose metabolism, diabetes and the vascular wall Glycation and autoxidation of proteins in aging and diabetes Lyons,T.J.;Thorpe,S.T.;Baynes,J.W.;Rudeman,N.(ed.)
  7. Cardiology Epidemiology, established major risk factor, and the primary prevention of coronary heart disease Stamlar,J.;Parmley,W.W.(ed.);Chatterjee,K.(ed.)
  8. Diabetes Metab. Rev. v.3 Diabetes and atherosclerosis : An elpidemiologic view Pyorala,K.;Laakso,M.;Uusitupa,M.
  9. Atherosclerosis v.6 Lipid and lipoprotein abnormalities associated with coronary heart disease in patients with insulin-dependent diabetes mellitus Laako,M.;Pyorala,K.;Sarlund,H.;Voutilainen,E.
  10. Diabetologia v.32 Hypertriglyceridemia as a risk factor of coronary heart disease mortality in subjects with impaired glucose tolerance or diabetes : Results from the 11-year follow-up of the Paris Prospective Study Fontbonne,A.;Eschwege,E.;Cambien,F.;Richard,J.L.;Ducimetiere,P.;Thibult,N.;Warnet,J.M.;Claude,J.R.;Rosselin,G.E.
  11. Arteriosclerosis v.8 Reduced atherogenesis in cholesterol-fedn diabetic rabbits Nordestegaard,B.G.;Stender,S.;Kjeldsen,K.
  12. J Clin. Endocrinol. Metab. v.61 Effects of noninsulin-dependent diabets mellitus on the uptake of very low density lipoproteins by thioglycolate-elicited mouse peritoneal macrophages Kraemer,F.B.;Chen,Y.D,I.;Lopez,R.D.;Reaven,G.M.
  13. Metabolism v.38 Interaction of very-low-density lipoprotein isolated from Type I(insulin-dependent) diabetic subjects with human monocyte-derived macrophages Klein,R.L.;Lyons,T.J.;Lopes-Virella,M.F.
  14. Diabetes v.31 Nonenzymatic glycosylation of low-density lipoprotein alters its biologic activity Witztum,J.L.;Mahoney,E.M.;Branks,M.J.;Fisher,M.;Elam,R.;Steinberg,D.
  15. Biochim. Biophys. Acta v.713 Glycosylation of LDL decreases its ability to interact with high affinity receptors of human fibroblasts in vitro and decreases its clearance from rabbit plasma in vivo Susaki,J.Cottam,G.L.
  16. Diabetes v.37 Glycosylation of LDL enhances CE synthesis in human monocyte-derived macrophages Lopes-Virella,M.F.;Klein,R.L.;Lyons,T.J.;Stevenson,H.C.;Witztum,J.L.
  17. Diabetes v.40 Nonenzymatic glycosylation of HDL and impaired HDL-receptor-mediated cholesterol efflux Duell,P.B.;Oram,J.F.;Bierman,E.L.
  18. Diabetes Care v.11 Role of advanced glycosylation products in complications of diabetes Cerami,A.;Vlassara,H.;Brownlee,M.
  19. J. Biol. Chem. v.85 End-stage renal disease and diabetes catalyze the formation of a pentose-derived cross link from aging human collagen Sell,D.R.;Monnier,V.M.
  20. Diabetes v.40 Role of oxidative stress in development of complications in diabetes Baynes,J.W.
  21. Diabetes v.34 Nonenzymatic glycosylation products on collagen covalently trap lowdensity lipoprotein Brownlee,M.;Vlassara,H.;Cerami,A.
  22. Proc. Natl. Acad. Sci. U.S.A. v.87 Advanced protein glycosylation induces transendothelial human monocyte chemotaxis and secretion of platelet-derived growth factor : Role in vascular disease of diabetes and aging Kirstein,M.;Brett,J.;Radoff,S.;Ogawa,S.;Stern,D.;Vlassara,H.
  23. Science v.232 Aminoguanidine prevents diabetes-induced artenal wall protein cross-linking Brownlee,M.;Vlassara,H.;Kooney,A.;Ulrich,P.;Cerami,A.
  24. N. Engl. J. Med. v.325 Advanced glycosylation end products in patients with diabetic nephropathy Makita,Z.;Radoff,S.;Rayfield,E.J.;Yang,Z.;Skolnik,E.;Delaney,V.;Friedman,E.A.;Cerami,A.;Vlassara,H.
  25. Diabetes v.41 Nonenzymatic glycosylation of macromolecules : prospects of pharmacologic modulation Brownlee,M.
  26. Diabetes v.41 Structural and functional changes of laminin and type 4 collagen after nonenzymatic glycosylation Charonis,A.S.;Tsilibary,F.E.C.
  27. Diabetes v.41 Role of oxygen in cross linking and chemical modification of collagen by glucose Fu,M.X.;Knecht,K.J.;Thorpe,S.R.;Baynes,J.W.
  28. Biochem. J. v.291 Oxidative alterations in the experimental glycosylation model of diabetes mellitus are due to protein-glucose adduct oxidation Hunt,J.V.;Bottoms,M.A.;Mitchinson,M.J.
  29. FEBS Lett. v.129 Nonenzymatic glycosylation of human serum lipoproteins Schleicher,E.;Deufel,T.;Wieland,O.H.
  30. Diabetologia. v.29 Glycosylation of low density lipoprotein in patients with type I diabetes : correlations with other parameters of glycaemic control Lyons,T.J.;Patrick,J.S.;Baynes,J.W.;Colwell,J.A.;Lopez-Virella,M.F.
  31. Diabetes v.33 Glycosylation of low density lipoproteins to an extent comparable to that seen in diabetes slows their catabolism Steinbrecher,U.P.;Witztum,J.L.
  32. Diabetes v.37 Glycosylation of low density lipoproteins enhances cholesteryl ester synthesis in human monocyte-derived macrophages Lopes-Virella,M.F.;Klein,R.L.;Lyons,T.J.;Stevenson,H.C.;Witztum,J.L.
  33. Diabetes v.39 Enhancement of platelet aggregation by the glycosylated subfraction of low density lipoprotein(LDL) isolated from patients with insulin-dependent diabetes mellitus(IDDM) Klein,R.L.;Lopes-Virella,M.F.;Colwell,J.A.
  34. Biochem. J. v.245 Glucose autoxidation and protein modification : the potential role of "autoxidative glycosylation" in diabetes mellitus Wolff,S.P.;Dean,R.T.
  35. J. Lipid Res. v.30 An immunochemical marker of low density lipoprotein oxidation Zawadzki,Z.;Milne,R.W.;Marcel,Y.L.
  36. Biochem. Biophys. Res. Commun. v.173 Free radical generation by early glycation products : a mechanism for accelerated atherogenesis in diabetes Mullarkey,C.J.;Edelstein,D.;Brownlee,M.
  37. Proc. Natl. Acad. Sci. USA v.90 Lipid advanced glycation pathway for lipid oxidation in-vivo Bucala,R.;Makita,Z.;Koschinsky,T.;Cerami,A.;Vlassara,H.
  38. JAMA v.260 Low density lipoprotein subclass patterns and risk of myocardial infarction Austin,M.A.;Breslow,J.L.;Hennekens,C.H.;Buring,J.E.;Willett,W.C.;Krauss,R.M.
  39. Diabetes Care v.14 Dyslipidaemia in type Ⅱ diabetes · implications for therapeutic intervention Stern,M.P.;Haffner,S.M.
  40. Am. J. Med. v.94 Susceptibility of small, dense, low density lipoproteins to oxidative modification in subjects with the atherogenic lipoprotein phenotype. pattern B. Chait,A.;Brazg,R.L.;Tribble,D.L.;Krauss,R.M.
  41. Diabetes v.37 Glycosylation of low density lipoproteins enhances cholesteryl ester synthesis in human monocyte-derived macrophages Lopez-Virella,M.F.;Klein,R.L.;Lyons,T.J.;Stevenson,H.C.;Witztum,J.L.
  42. Diabetes v.41 Immune mechanisms for atherosclerosis in diabetes mellitus Lopez-Virella,M.F.;Virella,G.
  43. Diabetes v.37 Enhancement of platelet aggregation by low density lipoproteins from IDDM patients Watanabe,J.;Wohltmann,H.J.;Klein,R.L.;Colwell,J.A.;Lopez-Virella,M.F.
  44. Diabetes v.40 Non-enzymatic glycosylation of HDL and impaired HDL-receptor-mediated cholesterol efflux Duell,P.B.;Oram,J.F.;Bierman,E.L.
  45. Science v.240 Cachectin/TNF and IL-1 induced by glucose-modified proteins : role in normal tissue remodeling Vlassara,H.;Brownlee,M.;Manogue,K.;Passgian,A.
  46. Circulation v.82 Advanced glycosylation end products selectively attract monocytes to migrate across endothelial cell monolayers, and induce activation and growth factor elaboration Brett,J.;Ogawa,S.;Kirstein,M.;Radoff,S.;Vlassara,H.;Stern,D.